CaMKII is activated by oxidation of methionine residues residing in the regulatory domain. Oxidized CaMKII (ox-CaMKII) is now thought to participate in cardiovascular and pulmonary diseases and cancer. This invited review summarizes current evidence for the role of ox-CaMKII in disease, considers critical knowledge gaps and suggests new areas for inquiry.
Keywords: Asthma; Atherosclerosis; Atrial fibrillation; CaMKII; Cancer; Heart failure; MsrA; Myocardial infarction; Sinus node dysfunction; Vascular smooth muscle; ox-CaMKII.
Copyright © 2015 Elsevier Ltd. All rights reserved.